Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 23, 2020ESC Heart FailureOpen Access

A Rise in Left Atrial Pressure Detected by the V-LAP™ System for Patients with Heart Failure During the Coronavirus Disease 2019 Pandemic

View Full Paper
Ask AI
Bookmark
Share

Key result

V-LAP remote monitoring detects rising LAP to guide treatment in a heart failure patient.

  • n=1

Why the study?

Remote monitoring of haemodynamic data during the COVID-19 pandemic presents an opportunity to detect and treat heart failure, but initial experiences with novel wireless left atrial pressure monitoring systems needed reporting.

Population

One 59-year-old man with severe ischaemic cardiomyopathy and LVEF -30%

Comparison

Remote haemodynamic monitoring using the V-LAP system

Design

Case report from a first-in-man clinical study

Follow-up

First 3 months after implantation

Authors

LPLeor PerlInterventional / Structural CardiologyBABinyamin Ben AvrahamHeart Failure / CardiomyopathyHVHana Vaknin‐AssaTel Aviv University

Discussion

Loading...

Member takes

Implication

Supports feasibility of wireless LAP monitoring in HF; hypothesis-generating for randomized outcome trials.

Study Design

Type

Case Report (n=1)

Blinding

Double-blind

Structured PICO

P
Population
A 59-year-old man with severe ischemic cardiomyopathy and heart failure monitored remotely using the V-LAP system during the COVID-19 pandemic.
I
Intervention
V-LAP™ wireless left atrial pressure (LAP) monitoring system
O
Outcome
Safety and feasibility of the V-LAP™ monitoring systemsurrogate

The V-LAP wireless left atrial pressure monitoring system is feasible for remote monitoring of heart failure patients, allowing detection of rising pressures to guide treatment.

Cite This Study

Perl et al. (2020) conducted a case report in Heart failure (n=1). V-LAP™ monitoring system was evaluated on Left atrial pressure (LAP). Remote monitoring using the V-LAP system detected a gradual increase in mean left atrial pressure from 6.56 to 19.4 mmHg in a heart failure patient, allowing for subsequent treatment.

synapsesocial.com/papers/6aa8e34816a2a0577c6bf6f0https://doi.org/10.1002/ehf2.13033

Topics

Heart failureHFrEF treatmentHeart failure hospitalization
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical Deterioration in Established Heart Failure: What is the Value of BNP and Weight Gain in Aiding Diagnosis?2005 · 180 citations
  2. 2Physician-Directed Patient Self-Management of Left Atrial Pressure in Advanced Chronic Heart Failure2010 · 319 citations
  3. 3Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial2018 · 766 citations
  4. 4Impact of Remote Telemedical Management on Mortality and Hospitalizations in Ambulatory Patients With Chronic Heart Failure2011 · 734 citations
  5. 5Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy2020 · 667 citations